Literature DB >> 16212420

Identification of protein fragments as pattern features in MALDI-MS analyses of serum.

Lisa J Zimmerman1, Gregory R Wernke, Richard M Caprioli, Daniel C Liebler.   

Abstract

The use of matrix-assisted laser desorption ionization mass spectrometry (MALDI-MS) to acquire spectral profiles has become a common approach to detect proteomic biomarkers of disease. MALDI-MS signals may represent both intact proteins as well as proteolysis products. Liquid chromatography-tandem mass spectrometry (LC-MS/MS) analysis can tentatively identify the corresponding proteins Here, we describe the application of a data analysis utility called FragMint, which combines MALDI-MS spectral data with LC-MS/MS based protein identifications to generate candidate protein fragments consistent with both types of data. This approach was used to identify protein fragments corresponding to spectral signals in MALDI-MS analyses of unfractionated human serum. The serum also was analyzed by one-dimensional SDS-PAGE and bands corresponding to the MALDI-MS signal masses were excised and subjected to in-gel digestion and LC-MS/MS analysis. Database searches mapped all of the identified peptides to abundant blood proteins larger than the observed MALDI-MS signals. FragMint identified fragments of these proteins that contained the MS/MS identified sequences and were consistent with the observed MALDI-MS signals. This approach should be generally applicable to identify protein species corresponding to MALDI-MS signals.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16212420     DOI: 10.1021/pr050138m

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  6 in total

1.  Diagnostic accuracy of MALDI mass spectrometric analysis of unfractionated serum in lung cancer.

Authors:  Pinar B Yildiz; Yu Shyr; Jamshedur S M Rahman; Noel R Wardwell; Lisa J Zimmerman; Bashar Shakhtour; William H Gray; Shuo Chen; Ming Li; Heinrich Roder; Daniel C Liebler; William L Bigbee; Jill M Siegfried; Joel L Weissfeld; Adriana L Gonzalez; Mathew Ninan; David H Johnson; David P Carbone; Richard M Caprioli; Pierre P Massion
Journal:  J Thorac Oncol       Date:  2007-10       Impact factor: 15.609

2.  Differentiating proteomic biomarkers in breast cancer by laser capture microdissection and MALDI MS.

Authors:  Melinda E Sanders; Eduardo C Dias; Baogang J Xu; James A Mobley; Dean Billheimer; Heinrich Roder; Julia Grigorieva; Mitchell Dowsett; Carlos L Arteaga; Richard M Caprioli
Journal:  J Proteome Res       Date:  2008-04-04       Impact factor: 4.466

3.  Sputter deposited bioceramic coatings: surface characterisation and initial protein adsorption studies using surface-MALDI-MS.

Authors:  A R Boyd; G A Burke; H Duffy; M Holmberg; C O' Kane; B J Meenan; P Kingshott
Journal:  J Mater Sci Mater Med       Date:  2010-11-21       Impact factor: 3.896

Review 4.  Biobanking for better healthcare.

Authors:  Peter H J Riegman; Manuel M Morente; Fay Betsou; Pasquale de Blasio; Peter Geary
Journal:  Mol Oncol       Date:  2008-07-30       Impact factor: 6.603

5.  Branched-chain amino acid metabolon: interaction of glutamate dehydrogenase with the mitochondrial branched-chain aminotransferase (BCATm).

Authors:  Mohammad Mainul Islam; Manisha Nautiyal; R Max Wynn; James A Mobley; David T Chuang; Susan M Hutson
Journal:  J Biol Chem       Date:  2009-10-26       Impact factor: 5.157

6.  Data from a comparative proteomic analysis of tumor-derived lung-cancer CD105(+) endothelial cells.

Authors:  Hongwei Jin; Xiao Cheng; Yihua Pei; Jianguo Fu; Zhi Lyu; Huifang Peng; Qin Yao; Yu Jiang; Lianzhong Luo; Huiqin Zhuo
Journal:  Data Brief       Date:  2016-03-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.